Supernumerary teeth EXCLUDE clefts and syndromes

K11_SUPNUM_ONLY

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions not K11_SUPNUM_EXCLUDE	557225
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K00.1 Cause of death: ICD-10 — K00.1 2 out of 7 registries used, show all original rules.	175
4. Check minimum number of events None	175
5. Include endpoints None	175
6. Filter based on genotype QC (FinnGen only)	158

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	K11_SUPNUM_ONLY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	!K11_SUPNUM_EXCLUDE
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K001
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K001
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Supernumerary teeth EXCLUDE clefts and syndromes based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	3723	1455	2264
Only index persons	3237	1262	1975
Unadjusted period prevalence (%)
Whole population	0.05	0.04	0.06
Only index persons	0.06	0.05	0.08
Median age at first event (years)
Whole population	10.23	10.55	9.98
Only index persons	10.76	11.25	10.45

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	158	85	73
Unadjusted period prevalence (%)	0.03	0.03	0.03
Median age at first event (years)	14.50	14.74	14.23

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
165: Matched controls
1650

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K00.10

ICD-10 Finland

The incisor and canine region, including the mesiodens

1164.2

110.6

K00.11

ICD-10 Finland

Excess teeth in the premolar region

+∞

25.7

K00.12

ICD-10 Finland

Excess teeth in the molar region

+∞

24.6

K00.19

ICD-10 Finland

Indefinite redundant teeth

139.4

23.2

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

9.6

21.1

EBA10

NOMESCO Finland

Operative extraction of tooth

4.5

20.9

325

EBA12

NOMESCO Finland

Demanding operative extraction of tooth

4.7

11.2

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

5.2

11.1

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

16.3

9.7

K00.1

ICD-10 Finland

Supernumerary teeth

+∞

9.5

SAA04

NOMESCO Finland

Special examination of mouth

3.7

8.4

K01.0

ICD-10 Finland

Embedded teeth

6.7

8.2

ECA00

NOMESCO Finland

Surgical exposure of tooth

17.6

6.8

EBB10

NOMESCO Finland

Insertion of dental implant

41.8

6.8

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3032080) INR in Blood by Coagulation assay

394

1.92

3.79

8.8

6.0

1.11

1.07

inr

0.45

329

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

165

2.08

3.07

1.3

1.6

3.09

3.42

mmol/l

1.02

114

(3021440) Promyelocytes/Leukocytes in Blood

2.44

2.79

2.4

5.7

0.20

0.25

—

(3001604) Monocytes [#/volume] in Blood

695

1.69

2.77

7.9

0.55

e9/l

0.11

600

(3006315) Basophils [#/volume] in Blood

696

1.69

2.75

8.1

7.9

0.04

e9/l

0.25

601

(3013115) Eosinophils [#/volume] in Blood

719

1.67

2.67

7.9

8.4

0.19

e9/l

0.08

639

(3019198) Lymphocytes [#/volume] in Blood

729

1.67

2.66

8.0

7.7

2.06

2.00

e9/l

0.31

655

(42870588) Differential panel, method unspecified - Blood

450

1.69

2.63

8.6

8.8

—

(3021788) Differential panel - Synovial fluid

4.82

2.62

1.3

1.5

—

(3022313) Gas panel - Capillary blood

2.31

2.52

17.1

7.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

147

2.00

2.52

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

155

0.30

2.44

1.2

2.2

2.41

mmol/l

—

140

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

105

2.15

2.44

15.4

7.0

1.11

1.34

mmol/l

0.14

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2.63

2.42

1.1

1.5

5.60

4.27

mg/l

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

5.14

2.42

1.5

8.1

—

(3017181) Myelocytes/Leukocytes in Blood

2.25

2.39

2.4

5.5

1.20

0.89

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

6.40

2.39

5.4

3.1

70.40

45.25

umol/l

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

772

1.62

2.37

9.1

9.9

3.99

4.05

e9/l

0.09

665

(3002179) Metamyelocytes/Leukocytes in Blood

2.28

2.34

2.5

5.3

0.60

0.50

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

206

1.82

2.31

1.4

1.7

3.29

3.46

ratio

0.30

153

(3042936) Bacteria identified in Isolate by Culture

153

1.91

2.25

2.0

2.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

153

1392

2.36

2.24

16.3

12.3

68.64

69.65

umol/l

0.31

153

1377

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

3.80

2.17

1.4

1.5

—

(3037121) Protein [Mass/volume] in Urine

2.56

2.16

6.3

8.7

189.43

446.03

mg/l

—

(3044640) Blood type and Crossmatch panel - Blood

408

1.61

2.11

2.8

2.4

—

(40761511) CBC panel - Blood by Automated count

154

1414

2.34

2.04

14.0

9.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.74

1.89

2.6

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

320

1.61

1.89

3.4

4.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

4.26

1.83

1.2

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

110

1.93

1.82

2.3

3.4

10.78

10.14

g/l

0.18

102

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

324

1.58

1.79

3.2

2.5

19.79

32.42

ng/l

0.37

144

(4034850) Laboratory test

3.00

1.74

2.0

8.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

148

1355

1.90

1.73

17.2

11.7

16.54

21.09

mg/l

1.51

123

1041

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

2.88

1.67

3.1

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

559

1.47

1.63

3.4

2.9

74.11

70.28

nmol/l

0.41

518

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

107

1.88

1.63

3.9

3.0

31.00

30.75

0.04

(40765089) Chromosome analysis panel - Blood by G-banded

3.65

1.62

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

2.57

1.62

1.6

4.2

—

(3002256) Pathology report gross observation

131

1.78

1.59

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

468

1.48

1.59

12.7

10.8

1.22

mmol/l

0.34

442

(3028026) IgM [Mass/volume] in Serum or Plasma

1.92

1.58

1.7

2.1

1.11

1.07

g/l

0.09

(3023368) Bacteria identified in Blood by Culture

238

1.60

1.57

4.1

4.6

—

(3013512) EKG study

250

1.56

1.48

3.5

2.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

597

1.43

1.46

3.6

3.0

—

estimate

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

3.19

1.45

3.6

6.2

3.42

5.89

pmol/l

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.19

1.45

1.0

1.1

—

(3035715) Granulocytes [#/volume] in Blood

2.47

1.41

4.1

4.5

3.04

3.71

e9/l

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.95

1.39

1.8

1.9

—

(3015736) pH of Urine

592

1.42

1.38

3.8

3.0

6.38

6.28

0.41

317

(4195642) Thrombophilia screening test

2.67

1.38

1.0

1.2

—

(1761868) Lipid panel - Serum or Plasma

521

1.41

1.30

2.6

2.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

512

1.41

1.29

13.1

10.2

1.22

mmol/l

0.05

449

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

108

1.75

1.28

1.3

1.5

274.17

265.19

miu/ml

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2.28

1.26

1.5

—

(3035933) Granulocytes/Leukocytes in Blood

2.28

1.26

3.8

3.9

49.63

55.76

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1.94

1.21

4.7

5.7

92.67

96.39

0.18

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

125

1129

1.44

1.20

12.0

9.5

103.39

101.79

ml/min/173m2

0.36

110

989

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

120

1077

1.42

1.18

5.2

4.0

14.35

14.60

pmol/l

0.63

115

986

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

112

0.43

1.18

2.4

1.7

—

(3047181) Lactate [Moles/volume] in Blood

0.00

1.17

0.0

18.9

—

1.22

—

(3029937) Albumin [Presence] in Urine by Test strip

353

1.42

1.16

3.8

3.3

0.18

0.01

estimate

0.44

136

(3013290) Carbon dioxide [Partial pressure] in Blood

2.54

1.16

5.0

4.3

5.22

4.97

kpa

—

(3027315) Oxygen [Partial pressure] in Blood

2.54

1.16

5.0

4.4

9.42

9.48

kpa

—

(3045424) Erythrocytes [Presence] in Urine

2.02

1.14

1.6

—

0.05

estimate

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1.82

1.10

1.2

1.1

1.70

3.85

u/ml

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

2.42

1.10

3.4

2.5

2.92

11.50

u/ml

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

297

1.41

1.02

2.9

2.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

100

1.66

1.01

24.4

21.4

24.63

25.01

mmol/l

0.17

100

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.91

0.99

1.9

1.7

—

(3010421) pH of Blood

2.27

0.94

4.5

4.1

7.40

7.41

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

135

1255

1.42

0.93

5.6

4.8

1.87

1.79

mu/l

0.41

128

1193

(3022145) Colonoscopy Study observation

111

1.59

0.92

1.9

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

2.11

0.90

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

163

1.48

0.88

2.3

2.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.04

0.88

1.2

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.72

0.88

1.0

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.97

0.85

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.97

0.85

1.7

1.4

—

(4035726) Immunohistochemistry procedure

1.69

0.84

1.3

1.5

—

(3000991) Gas panel - Venous blood

115

1.53

0.80

11.9

16.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.70

0.80

2.1

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.79

0.77

1.0

1.1

—

3.29

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1.79

0.77

2.7

3.1

64.42

50.21

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

396

1.30

0.76

1.8

1.7

98.87

96.18

pmol/l

0.15

207

(1616796) Gas panel - Central venous blood

2.12

0.75

4.2

4.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

313

1.32

0.75

2.0

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

498

0.76

0.74

3.3

2.5

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

100

905

1.27

0.74

6.6

4.0

7.44

8.10

mm/h

0.32

849

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.64

0.74

3.0

1.5

3.39

3.60

ug/l

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.74

0.71

9.0

27.2

0.60

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.74

0.71

1.9

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

868

1.25

0.70

11.0

6.7

92.89

80.23

u/l

1.35

820

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.68

0.70

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.66

0.67

1.6

2.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.81

0.66

1.0

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1.52

0.66

11.8

13.4

24.15

23.92

mmol/l

0.10

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.62

0.66

9.0

25.5

0.97

1.58

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.62

0.66

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.62

0.66

1.1

1.5

—

(40758558) Short blood count panel - Blood

394

1.27

0.65

7.0

7.3

—

(3000492) Spirometry study

152

0.64

0.65

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

159

1547

1.76

0.64

23.6

17.2

137.30

138.27

g/l

0.39

159

1533

(3035941) MCH [Entitic mass]

159

1546

1.78

0.64

23.4

16.9

29.85

29.87

0.05

159

1531

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

159

1546

1.78

0.64

23.6

17.8

41.08

41.12

0.04

159

1530

(3024731) MCV [Entitic mean volume] in Red Blood Cells

159

1545

1.80

0.64

23.3

16.9

89.10

88.92

0.22

159

1531

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.50

0.64

2.2

2.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

540

0.79

0.63

3.3

2.7

—

(3019150) Specific gravity of Urine by Refractometry

331

1.28

0.62

4.5

2.6

1.01

1.02

kg/l

0.92

210

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

559

0.80

0.61

2.2

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

123

1.43

0.61

11.0

11.1

5.65

5.83

kpa

0.34

118

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.60

0.0

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.52

0.59

2.0

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.51

0.58

1.0

1.1

—

6.53

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.69

0.57

1.0

1.2

—

(3002032) Base excess in Venous blood by calculation

125

1.40

0.56

11.0

10.9

0.83

1.67

mmol/l

0.41

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

392

1.24

0.56

5.5

4.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.52

0.55

1.0

1.1

0.88

0.87

g/l

0.06

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.50

0.55

1.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

262

1.27

0.54

2.8

2.6

0.90

1.27

mg/l

0.41

183

(3022621) pH of Urine by Test strip

109

1.41

0.53

1.7

1.8

6.13

6.19

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

137

1.35

0.50

1.3

145.34

113.26

u/ml

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

155

1.33

0.49

3.0

2.6

4189.43

4750.53

u/l

0.07

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.48

0.49

1.2

1.3

—

(3018418) pH of Serum or Plasma

303

1.24

0.49

5.1

3.9

7.40

7.39

0.54

215

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

165

1.31

0.48

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

453

0.82

0.47

2.4

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

0.59

0.47

1.0

1.1

—

(3002582) Erythrocytes [#/volume] in Urine

363

1.21

0.45

4.5

3.9

7.24

52.09

e6/l

1.66

272

(3021601) Nitrite [Presence] in Urine by Test strip

704

1.18

0.44

4.0

3.4

0.00

estimate

-0.00

142

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1.63

0.43

2.4

2.7

92.00

479.63

ug/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.42

0.43

3.9

2.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

375

1.20

0.42

1.8

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

478

0.84

0.41

1.8

1.12

1.32

mmol/l

1.15

424

(3047352) Trisomy 18 risk [Likelihood] in Fetus

103

0.67

0.41

2.0

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.35

0.41

3.3

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

104

0.66

0.41

2.1

1.6

—

(36660697) Celiac disease serology panel - Serum

203

0.77

0.41

1.3

1.2

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

131

1256

1.21

0.40

16.9

14.9

13.22

13.15

0.32

131

1243

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

207

1.24

0.39

2.6

3.7

0.74

0.88

e6/l

0.13

118

(3035350) Ketones [Presence] in Urine by Test strip

709

1.16

0.39

4.0

3.4

0.00

estimate

-0.00

139

(3014051) Protein [Presence] in Urine by Test strip

434

0.84

0.39

2.9

—

0.00

—

(3025130) Human papilloma virus identified in Specimen

1.40

0.38

1.4

1.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

190

0.77

0.38

1.4

3.0

124.50

228.69

ng/l

—

108

(3018095) Leukocytes [#/volume] in Urine

466

1.17

0.37

5.0

4.7

14.11

31.20

e6/l

1.23

296

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.62

0.36

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

119

1136

1.17

0.36

3.7

3.2

5.39

5.57

mmol/l

0.97

111

1050

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

133

1281

1.20

0.36

17.4

14.5

334.44

334.90

g/l

0.28

133

1273

(3009261) Glucose [Presence] in Urine by Test strip

713

1.15

0.36

3.8

3.5

0.00

estimate

-0.00

132

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.41

0.35

1.7

1.9

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.39

0.35

1.0

1.1

1.58

1.51

g/l

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

109

1.31

0.35

6.4

15.0

104.71

104.39

mmol/l

0.08

109

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

325

0.83

0.34

3.5

2.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

128

1.28

0.33

1.8

1.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.35

0.33

1.1

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1.29

0.32

1.2

2.7

36.00

92.93

ng/l

—

(3016879) Cocaine [Presence] in Urine

206

0.81

0.31

1.6

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

291

1.17

0.29

2.6

2.7

88.27

87.33

ug/g

0.01

224

(3030467) Casts [#/volume] in Urine by Automated count

322

1.15

0.26

3.0

3.9

0.20

0.25

e6/l

0.18

231

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

497

1.13

0.26

2.1

1.9

—

(1002224) Polysomnography panel

0.66

0.26

1.0

1.1

—

(3021589) Normoblasts [#/volume] in Blood

655

0.89

0.26

12.7

10.5

0.00

e9/l

0.80

522

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.30

0.25

4.3

5.2

—

(3026008) Bacteria identified in Urine by Culture

324

1.14

0.24

1.5

2.2

—

(3003694) ABO and Rh group [Type] in Blood

530

1.12

0.23

2.0

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.26

0.23

1.2

1.5

—

(40768804) Tissue Pathology biopsy report

442

1.12

0.23

2.5

1.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

417

0.88

0.23

4.2

2.7

0.25

0.00

estimate

0.47

118

(3023511) Choriogonadotropin [Units/volume] in Urine

0.75

0.23

1.3

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.21

0.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3036603) Volume of Urine

0.00

0.21

0.0

2.6

—

1546.50

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

6.24

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.21

0.0

9.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

13.51

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

1653.08

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.21

0.0

1.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

0.21

0.0

6.6

—

9.23

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.21

0.0

3.3

—

45.38

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

455

1.11

0.20

1.7

1.6

2.16

2.04

g/l

0.38

274

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

102.50

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1.21

0.20

1.3

2.0

37.33

35.98

u/l

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.18

0.19

1.0

1.4

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

119

1.19

0.18

1.3

1.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

196

1.14

0.17

2.7

3.9

8.84

3.21

e6/l

0.62

108

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.74

0.17

1.2

1.7

—

5.36

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

101

1.20

0.17

1.7

1.6

0.13

0.25

mg/l

—

(3037467) Urinalysis macro (dipstick) panel - Urine

892

0.93

0.16

6.6

4.3

—

(3025941) Bacteria identified in Stool by Culture

1.13

0.15

1.9

1.2

—

(21494755) Public health laboratory ask at order entry panel

189

1.13

0.14

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

221

0.89

0.13

1.4

1.3

0.94

7.43

u/ml

—

(3012516) Albumin [Mass/volume] in Urine

230

0.90

0.12

5.1

3.7

24.54

70.89

mg/l

1.75

156

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

240

1.10

0.12

1.4

1.3

10.27

22.37

iu/ml

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

124

1.14

0.11

1.4

1.3

—

(3000494) Fungus identified in Specimen by Culture

124

1.14

0.11

2.1

1.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

527

1.07

0.11

4.2

2.9

0.23

0.01

estimate

0.45

122

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

115

1.14

0.11

4.0

3.3

20.64

20.58

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.17

0.10

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

176

0.90

0.10

1.4

1.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

529

1.06

0.09

1.6

1.5

0.51

1.77

u/ml

2.13

118

(40768797) Stomach Pathology biopsy report

126

1.12

0.09

1.8

1.2

—

(40761536) Microorganisms panel - Urine sediment

126

1.12

0.09

2.7

3.6

—

(3027944) Amphetamines [Presence] in Urine

225

0.92

0.08

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.13

0.08

3.5

2.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

153

0.91

0.07

1.6

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1.09

0.07

7.6

20.9

4.68

5.15

kpa

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1.09

0.07

7.6

20.9

16.62

15.55

kpa

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.84

0.07

1.4

1.6

40.59

53.89

ug/l

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

129

1.09

0.06

2.5

2.6

30.07

28.31

u/l

0.12

105

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

282

0.95

0.05

3.0

2.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

130

1288

1.04

0.04

3.6

3.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

200

1.06

0.04

1.5

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

149

0.93

0.03

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

148

0.94

0.02

1.6

2.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

228

0.96

0.02

6.0

4.3

3.36

10.94

mg/mmol

1.55

152

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

114

0.96

0.00

2.2

1.9

—

(3027008) Opiates [Presence] in Urine

224

0.98

0.00

1.6

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

231

0.99

0.00

3.3

3.6

311.09

329.43

umol/l

0.37

217

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

117

1.03

0.00

1.7

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

643

0.99

0.00

2.6

2.4

—

(3028300) Cannabinoids [Presence] in Urine

225

0.97

0.00

1.6

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

115

1.05

0.00

2.1

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

268

1.01

0.00

1.4

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

1.94

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.00

0.0

2.1

—

187.50

—

(3020650) Glucose [Presence] in Urine

0.00

0.0

1.3

—

0.00

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3006462) Nitrate [Presence] in Urine

0.00

-0.00

0.0

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

-0.00

0.0

2.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

-0.00

0.0

1.9

—

11.29

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.91

-0.00

1.6

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

220

1.00

-0.00

1.6

1.7

—

(3008898) HLA-B27 [Presence]

1.00

-0.00

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

3.98

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

-0.00

0.0

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

3.25

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

803.67

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

-0.00

0.0

1.1

—

(4211845) Urine protein measurement

0.00

-0.00

0.0

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.2

—

1110.50

—

(4038314) Semen analysis, post vasectomy

0.00

-0.00

0.0

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.02

-0.00

2.2

12.1

0.54

0.60

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

85.43

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

-0.00

0.0

1.3

—

8.37

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

53.17

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

0.00

-0.00

0.0

1.0

—

1.87

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.4

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

-0.00

0.0

4.3

—

103.84

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.00

-0.00

0.0

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

-0.00

0.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

51.83

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.2

—

(3024263) Appearance of Synovial fluid

0.00

-0.00

0.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

0.93

-0.00

1.4

2.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

-0.00

0.0

3.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(40761535) Cells panel - Urine sediment

0.89

-0.00

7.0

2.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_SUPNUM_ONLY and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_SUPNUM_ONLY.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: K11_SUPNUM_ONLY – Supernumerary teeth EXCLUDE clefts and syndromes

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Supernumerary teeth EXCLUDE clefts and syndromes

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints